Loading organizations...
§ Private Profile · Toronto, ON, Canada
Medical device company developing autoRIC device for RIC therapy, protecting heart muscles during heart attacks.
Founded in 2009 and based in Toronto, Ontario, CellAegis Devices develops the noninvasive autoRIC device to automate remote ischemic conditioning therapy for cardiovascular healthcare. This wearable technology applies brief periods of restricted blood flow to the arm, activating biological defense mechanisms that protect heart muscles and reduce organ damage by up to fifty percent. Led by Chief Executive Officer Rocky Ganske, the medical device company has secured nearly ten million dollars in total equity funding from investors including Broadview Ventures, CTI Life Sciences Fund, Amplify Capital, and Medica Partners. A massive Series C financing round provided the growing enterprise with essential venture capital to support clinical trials and commercialize its proprietary medical system. Backed by nine successfully filed patents, the organization currently markets its innovative cardiovascular technology to patients suffering from heart attacks across Europe and Canada.
CellAegis Devices has raised $9.5M across 1 funding round.
CellAegis Devices has raised $9.5M in total across 1 funding round.
CellAegis Devices has raised $9.5M across 1 funding round. Most recently, it raised $9.5M Series C in March 2017.
| Date | Round | Lead Investors | Other Investors | Status |
|---|---|---|---|---|
| Mar 14, 2017 | $9.5M Series C | Shermaine Tilley | Amplify Capital, Chris Colecchi | Announced |
CellAegis Devices has raised $9.5M in total across 1 funding round.
CellAegis Devices's investors include Shermaine Tilley, Amplify Capital, Chris Colecchi.